VANECK PHARMACEUTICAL ETF (PPH) Institutional Ownership and Insiders Activity
VANECK PHARMACEUTICAL ETF (PPH) is widely held by institutional investors, with 151 firms reporting positions valued at approximately $670.77M based on SEC Form 13F filings for the quarter ended June 30, 2026.
Goldman Sachs Group Inc is the largest disclosed holder, reporting approximately $128.92M in PPH holdings in its latest filing.
Institutional Holders
151
Total Reported Value
$670.77M
Largest Holder
Goldman Sachs Group Inc
Largest Position
$128.92M
Insider Transactions (90d)
0
Latest Filing Quarter
Q2 2026
New Institutional Positions
140
Funds Exiting Positions
1
Top Institutional Owners
View allInvestorReported Balance
- Goldman Sachs Group Inc$128.92M
- Morgan Stanley$112.45M
- Ubs Group Ag$56.62M
- Healthcare Of Ontario Pension Plan Trust Fund$43.96M
- Bnp Paribas Financial Markets$38.34M
PPH News
All news- Rye Brook Capital LLC Investment Activity in Q1 2026
Jul 22, 2026 · valut.ai